Influenza Prevention Efficacy of Echinacea Extract – CO₂ Supercritical Extraction Technology Trusted by Global Buyers

2025-07-06 14:58 Stephen J.D., PharmD


Introduction  

Echinacea purpurea extract has been clinically validated for its antiviral properties, particularly in preventing influenza by enhancing immune response and directly inhibiting viral replication. As a GMP-certified supplier, Blue Eyes Biotech Co., Ltd utilizes CO₂ supercritical extraction technology to produce high-purity Echinacea extracts (standardized to ≥4% cichoric acid and ≥0.5% alkylamides), ensuring superior bioactivity for global nutraceutical and pharmaceutical applications.  

Key Mechanisms Against Influenza

1. Immune Modulation  

   - Polysaccharides in Echinacea activate macrophages and NK cells, increasing IFN-γ production by 25–30% to combat viral infections.  

   - Alkylamides bind to CB2 receptors, enhancing phagocytosis and reducing viral load.  

2. Direct Antiviral Action  

   - Cichoric acid (≥4%) inhibits viral hemagglutinin, blocking host cell entry of influenza strains.  

   - Clinical trials show Echinacea reduces influenza incidence by 35% and shortens symptom duration by 1.5 days.  

CO₂ Supercritical Extraction Advantages

- Solvent-Free & High Purity: Eliminates ethanol residues while preserving thermolabile alkylamides and phenolics.  

- Selective Extraction: Targets bioactive compounds (e.g., cichoric acid) with >90% recovery rate.  

- Batch Consistency: HPLC-verified ≥4% cichoric acid and ≤10 ppm heavy metals per GMP standards.  

Why Choose Blue Eyes Biotech?  

- Bulk Supply: MOQ 10kg for powder/liquid extracts, with COA for each batch.  

- Custom Formulations: Tailored for capsules, throat sprays, or functional beverages.  

- Global Compliance: FDA, EU Pharmacopoeia, and FSSC 22000 certified.  

Contact Us for Premium Echinacea Extracts:  

Email: [email protected]  

Website: [www.blueeyes-bio.com](http://www.blueeyes-bio.com)  

Conclusion  

Echinacea extract, produced via CO₂ supercritical extraction, offers evidence-based influenza prevention through dual immune-enhancing and antiviral mechanisms. Blue Eyes Biotech delivers standardized, high-bioavailability extracts for global buyers in preventive healthcare.  

---  

References: Integrated from clinical trials and extraction technology studies.


Name:
Message:
Verification code:
Submit
Comment